- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,773,190
- Total 13F shares
- 56,388,612
- Share change
- -10,774,673
- Total reported value
- $263,332,828
- Put/Call ratio
- 69%
- Price per share
- $4.67
- Number of holders
- 229
- Value change
- -$55,730,958
- Number of buys
- 108
- Number of sells
- 109
Quarterly Holders Quick Answers
What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28106W103:
Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
11%
|
8,760,151
|
$65,000,320 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
8,555,597
|
$63,482,530 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.5%
|
7,832,781
|
$58,119,233 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
6.7%
|
5,527,290
|
$41,012,492 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.2%
|
2,607,765
|
$19,349,617 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.7%
|
2,261,645
|
$16,803,929 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.7%
|
2,236,617
|
$16,595,698 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,944,763
|
$14,431,993 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.2%
|
1,783,732
|
$13,235,293 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.7%
|
1,400,932
|
$10,394,916 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.7%
|
1,387,982
|
$10,298,826 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.5%
|
1,234,300
|
$9,158,506 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.3%
|
1,089,240
|
$8,082,161 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
1.3%
|
1,045,255
|
$7,755,792 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.2%
|
1,023,180
|
$7,591,995 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.2%
|
981,521
|
$7,282,886 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.1%
|
903,257
|
$6,702,167 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
1.1%
|
898,456
|
$6,666,544 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.1%
|
898,418
|
$6,666,000 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
896,647
|
$6,653,119 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.1%
|
895,000
|
$6,640,900 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
856,095
|
$6,352,225 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
1%
|
853,114
|
$6,330,106 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
832,880
|
$6,179,970 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.96%
|
791,320
|
$5,871,595 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.86%
|
715,917
|
$5,312,104 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.84%
|
691,933
|
$5,134,144 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.72%
|
595,965
|
$4,422,061 | — | 31 Mar 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.54%
|
450,000
|
$3,339,000 | — | 31 Mar 2024 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.43%
|
351,822
|
$2,610,519 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.38%
|
314,774
|
$2,246,344 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.35%
|
292,710
|
$2,171,908 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.34%
|
284,822
|
$2,113,378 | — | 31 Mar 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.33%
|
275,069
|
$2,041,012 | — | 31 Mar 2024 | |
| STATE OF MICHIGAN RETIREMENT SYSTEM |
13F
|
Company |
0.33%
|
273,721
|
$2,031,010 | — | 31 Mar 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.28%
|
233,703
|
$1,734,077 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
210,348
|
$1,560,782 | — | 31 Mar 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.24%
|
199,205
|
$1,478,101 | — | 31 Mar 2024 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
0.22%
|
182,673
|
$1,355,434 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.21%
|
175,555
|
$1,302,618 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.2%
|
164,874
|
$1,223,365 | — | 31 Mar 2024 | |
| Michelle Robertson |
3/4/5
|
EVP, CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
106,610
|
$1,161,750 | — | 11 May 2023 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.18%
|
147,883
|
$1,097,292 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.17%
|
144,800
|
$1,074,416 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.17%
|
144,723
|
$1,073,844 | — | 31 Mar 2024 | |
| David M. Knott Jr. |
13F
|
Individual |
0.17%
|
140,000
|
$1,039,000 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.16%
|
134,124
|
$995,188 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.16%
|
133,214
|
$988,448 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.16%
|
128,852
|
$956,079 | — | 31 Mar 2024 | |
| PROFUND ADVISORS LLC |
13F
|
Company |
0.15%
|
123,841
|
$918,900 | — | 31 Mar 2024 |
Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q2 2024
As of 30 Jun 2024,
Editas Medicine, Inc. - Common Stock (EDIT) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,388,612 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Deep Track Capital, LP, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, Pictet Asset Management Holding SA, GOLDMAN SACHS GROUP INC, and Woodline Partners LP.
This page lists
230
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
221
Q2 2024 holders
229
Holder diff
8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.